Incidence, serogroups and case-fatality rate of invasive meningococcal infections in a Swedish region 1975-1989.
暂无分享,去创建一个
[1] W. M. Shepherd,et al. Immunogenicity in adult males of a Neisseria meningitidis group B vaccine composed of polysaccharide complexed with outer membrane proteins. , 1991, Vaccine.
[2] T. S. Tang,et al. Fatal coxsackie B1 virus infection in neonates , 1989, The Pediatric infectious disease journal.
[3] Varughese Pv. Meningococcal disease in Canada: surveillance summary to 1987. , 1989 .
[4] W. Hitchcock,et al. Meningococcal infections in children: a review of 100 cases. , 1989, The Pediatric infectious disease journal.
[5] D. Lennon,et al. An outbreak of meningococcal disease in Auckland, New Zealand. , 1989, The Pediatric infectious disease journal.
[6] A. Sjöholm,et al. Another Swedish family with complete properdin deficiency: association with fulminant meningococcal disease in one male family member. , 1989, Scandinavian journal of infectious diseases.
[7] P. Magnussen,et al. Complement deficiencies in selected groups of patients with meningococcal disease. , 1989, Scandinavian journal of infectious diseases.
[8] S. Harthug,et al. Antibody responses to serogroup B meningococcal outer membrane antigens after vaccination and infection , 1988, Journal of clinical microbiology.
[9] B. Claesson,et al. Haemophilus influenzae meningitis in Sweden 1981-1983. , 1987, Archives of disease in childhood.
[10] I. Brandslund,et al. Screening for complement deficiencies in unselected patients with meningitis. , 1987, Clinical and experimental immunology.
[11] P. Olcén,et al. Increased incidence of childhood bacterial meningitis. A 25-year study in a defined population in Sweden. , 1987, Scandinavian journal of infectious diseases.
[12] J. Winkelstein,et al. Prevalence of complement deficiencies in children with systemic meningococcal infections. , 1987, The Pediatric infectious disease journal.
[13] A. Halstensen,et al. Case fatality of meningococcal disease in western Norway. , 1987, Scandinavian journal of infectious diseases.
[14] H. Zanen,et al. MENINGOCOCCAL SEROTYPES AND SEROGROUP B DISEASE IN NORTH-WEST EUROPE , 1986, The Lancet.
[15] C. Adamsbaum,et al. AGE-SPECIFIC DIFFERENCES IN DURATION OF CLINICAL PROTECTION AFTER VACCINATION WITH MENINGOCOCCAL POLYSACCHARIDE A VACCINE , 1985, The Lancet.
[16] R. Norrby,et al. Invasive pneumococcal infections: incidence, predisposing factors, and prognosis. , 1985, Reviews of infectious diseases.
[17] M. Lepow,et al. Editorial retrospective. Meningococcal A and other polysaccharide vaccines. A five-year progress report. , 1983, The New England journal of medicine.
[18] H. Peltola. Meningococcal disease: still with us. , 1983, Reviews of infectious diseases.
[19] H. Peltola,et al. Meningococcal disease in Scandinavia. , 1982, British medical journal.
[20] B. Greenwood,et al. Is there a genetic immune defect in families with meningococcal meningitis? , 1981, The Journal of infection.
[21] E. Gotschlich,et al. Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines. , 1977, Pediatrics.